Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wish list failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)
-
Narrated by:
-
Written by:
About this listen
In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
In this episode, Alfred (Al) Kim, a rheumatologist from the Washington University School of Medicine in St Louis, Missouri, USA, talks about hydroxychloroquine. He discusses why the drug was initially considered promising but later shown to be ineffective, and describes the impact drug shortages have had on rheumatology practice.
Find more on Medicine Matters rheumatology